Background: World Health Organization (WHO) data collection of Escherichia coli resistant to cephalosporin generation III already confirmed in 86 countries. Incredibly high carrier prevalence rates were also widely developed in Thailand, Egypt, and China. The Faculty of Medicine's research team at Jenderal Soedirman University, Purwokerto, discovered at the beginning of 2018 that Extended Spectrum β-Lactamase (ESBL) E. coli carriers throughout the 2015 class students were 26.8 percent. Objective: This research investigated the Prevalence and associated factors of ESBL-producing Enterobacteriaceae (EPE) asymptomatic carriers in the community. Methods: The participant fill a questionnaire, and samples were taken from rectal swabs using Ami...
Purpose: A point prevalence study was carried out in a teaching hospital in Assam to determine the p...
Background: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli i...
International audienceBACKGROUND:Nothing is known about the epidemiology and resistance mechanisms o...
Background: World Health Organization (WHO) data collection of Escherichia coli resistant to cephalo...
Background. The world prevalence of community and hospital-acquired extended-spectrum β-lactamase (E...
BACKGROUND:The isolation of Extended spectrum βlactamase (ESBLs) producing Enterobacteriaceae among ...
Objectives: Intestinal colonization by ESBL Escherichia coli and its association with community-acqu...
Introduction: Antibiotic resistance in Enterobacteriaceae producing extended spectrum beta-lactamase...
In human medicine, the most important family of bacteria is Enterobacteriaceae, which includes gener...
Background: Antibiotic resistance in pathogens, especially Escherichia coli, has become a major trea...
Objective To investigate the molecular characteristics of extended-spectrum cephalosporin (ESC)-re-s...
Aim: This study aimed to investigate the frequency and molecular epidemiology of class A ESBLs produ...
BACKGROUND: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli is i...
International audienceBACKGROUND:Nothing is known about the epidemiology and resistance mechanisms o...
Purpose: A point prevalence study was carried out in a teaching hospital in Assam to determine the p...
Purpose: A point prevalence study was carried out in a teaching hospital in Assam to determine the p...
Background: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli i...
International audienceBACKGROUND:Nothing is known about the epidemiology and resistance mechanisms o...
Background: World Health Organization (WHO) data collection of Escherichia coli resistant to cephalo...
Background. The world prevalence of community and hospital-acquired extended-spectrum β-lactamase (E...
BACKGROUND:The isolation of Extended spectrum βlactamase (ESBLs) producing Enterobacteriaceae among ...
Objectives: Intestinal colonization by ESBL Escherichia coli and its association with community-acqu...
Introduction: Antibiotic resistance in Enterobacteriaceae producing extended spectrum beta-lactamase...
In human medicine, the most important family of bacteria is Enterobacteriaceae, which includes gener...
Background: Antibiotic resistance in pathogens, especially Escherichia coli, has become a major trea...
Objective To investigate the molecular characteristics of extended-spectrum cephalosporin (ESC)-re-s...
Aim: This study aimed to investigate the frequency and molecular epidemiology of class A ESBLs produ...
BACKGROUND: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli is i...
International audienceBACKGROUND:Nothing is known about the epidemiology and resistance mechanisms o...
Purpose: A point prevalence study was carried out in a teaching hospital in Assam to determine the p...
Purpose: A point prevalence study was carried out in a teaching hospital in Assam to determine the p...
Background: The number of extended-spectrum beta-lactamase (ESBL) positive (+) Escherichia coli i...
International audienceBACKGROUND:Nothing is known about the epidemiology and resistance mechanisms o...